Combined Multi-marker Screening and Randomised Patient Treatment with Aspirin for Evidence-based Pre-eclampsia Prevention

Project Information

ASPRE

Grant agreement ID: 601852

Project closed

Start date 1 May 2013

End date 31 October 2016

Funded under

• Specific Programme "Cooperation": Health

Total cost € 7 556 140,90

EU contribution € 5 839 800,00

Coordinated by

FETAL MEDICINE FOUNDATION
United Kingdom